Characteristics of and risk factors for COVID-19 breakthrough infections in idiopathic inflammatory myopathies: results from the COVAD study

Hoff LS;Ravichandran N;Sen P;Day J;Joshi M;Nune A;Nikiphorou E;Saha S;Tan AL;Shinjo SK;Ziade N;Velikova T;Milchert M;Jagtap K;Parodis I;Gracia-Ramos AE;Cavagna L;Kuwana M;Knitza J;Chen YM;Makol A;Agarwal V;Patel A;Pauling JD;Wincup C;Barman B;Tehozol EAZ;Serrano JR;Torre IG;Colunga-Pedraza IJ;Merayo-Chalico J;Chibuzo OC;Katchamart W;Goo PA;Shumnalieva R;El Kibbi L;Halabi H;Vaidya B;Shaharir SS;Hasan ATMT;Dey D;Gutiérrez CET;Caballero-Uribe CV;Lilleker JB;Salim B;Gheita T;Chatterjee T;Distler O;Saavedra MA;Chinoy H;Agarwal V;Aggarwal R;Gupta L;Sambataro G;among the COVAD Study Group.

2025-01-01